Literature DB >> 10696080

Cardiotoxic effects of fenfluramine hydrochloride on isolated cardiac preparations and ventricular myocytes of guinea-pigs.

S Rajamani1, C Studenik, R Lemmens-Gruber, P Heistracher.   

Abstract

The cardiotoxic effects of fenfluramine hydrochloride on mechanical and electrical activity were studied in papillary muscles, Purkinje fibres, left atria and ventricular myocytes of guinea-pigs. Force of contraction (f(c)) was measured isometrically, action potentials and maximum rate of rise of the action potential (V(max)) were recorded by means of the intracellular microelectrode technique and the sodium current (I(Na)) with patch-clamp technique in the cell-attached mode. For kinetic analysis (S)-DPI-201-106-modified Na(+) channels from isolated guinea-pig ventricular heart cells were used. Fenfluramine (1 - 300 microM) produced negative chronotropic and inotropic effects; additional extracellular Ca(2+) competitively antagonized the negative inotropic effect. Fenfluramine concentration-dependently reduced V(max) and showed tonic blockade of sodium channels, shortened the action potential duration in papillary muscles and Purkinje fibres. In cell-attached patches, fenfluramine decreased I(Na) concentration-dependently (10 - 100 microM), frequency-independently (0.1 - 3 Hz; 30 microM). The h(infinity) curve was shifted towards hyperpolarizing direction. At 30 microM, fenfluramine blocked the sodium channel at all test potentials to the same degree, and neither changed the threshold and reversal potentials nor the peak of the curve. No effect on single channel availability, but a significant decrease in mean open times and increase in mean closed times was observed. Mean duration of the bursts decreased and number of openings per record increased with increasing drug concentration. It is concluded that the effect on I(Na) plays an important role in the cardiotoxicity of fenfluramine in addition to primary pulmonary hypertension and valvular disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10696080      PMCID: PMC1571904          DOI: 10.1038/sj.bjp.0703118

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs.

Authors:  M A Khan; C A Herzog; J V St Peter; G G Hartley; R Madlon-Kay; C D Dick; R W Asinger; J T Vessey
Journal:  N Engl J Med       Date:  1998-09-10       Impact factor: 91.245

2.  Further cases of valvular heart disease associated with fenfluramine-phentermine.

Authors:  D J Graham; L Green
Journal:  N Engl J Med       Date:  1997-08-28       Impact factor: 91.245

3.  Valvular heart disease associated with dexfenfluramine.

Authors:  L B Cannistra; S M Davis; A G Bauman
Journal:  N Engl J Med       Date:  1997-08-28       Impact factor: 91.245

4.  Dreaming, fenfluramine, and vitamin C.

Authors:  A Mullen; C W Wilson; B P Wilson
Journal:  Br Med J       Date:  1977-01-08

5.  Mechanism of action of antifibrillatory drugs.

Authors:  P Heistracher
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

6.  [Evaluation of inotropically active drugs on isolated papillary muscle].

Authors:  M Reiter
Journal:  Arzneimittelforschung       Date:  1967-10

7.  An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group.

Authors:  N J Weissman; J F Tighe; J S Gottdiener; J T Gwynne
Journal:  N Engl J Med       Date:  1998-09-10       Impact factor: 91.245

8.  A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.

Authors:  H Jick; C Vasilakis; L A Weinrauch; C R Meier; S S Jick; L E Derby
Journal:  N Engl J Med       Date:  1998-09-10       Impact factor: 91.245

9.  Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services interim public health recommendations, November 1997.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-11-14       Impact factor: 17.586

10.  Fenfluramine poisoning.

Authors:  J C Veltri; A R Temple
Journal:  J Pediatr       Date:  1975-07       Impact factor: 4.406

View more
  2 in total

1.  Cytochrome P450 mono-oxygenase gene expression and protein activity in cultures of adult cardiomyocytes of the rat.

Authors:  T Thum; J Borlak
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 2.  Fenfluramine: A Review of Pharmacology, Clinical Efficacy, and Safety in Epilepsy.

Authors:  Debopam Samanta
Journal:  Children (Basel)       Date:  2022-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.